Buse Balci

474 total citations · 1 hit paper
12 papers, 347 citations indexed

About

Buse Balci is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Oncology. According to data from OpenAlex, Buse Balci has authored 12 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Nephrology and 3 papers in Oncology. Recurrent topics in Buse Balci's work include Inflammatory Biomarkers in Disease Prognosis (3 papers), Gout, Hyperuricemia, Uric Acid (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Buse Balci is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (3 papers), Gout, Hyperuricemia, Uric Acid (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Buse Balci collaborates with scholars based in Türkiye. Buse Balci's co-authors include Gülali Aktaş, Tuba Taslamacıoğlu Duman, Burçin Meryem Atak Tel, Satılmış Bilgin, Özge Kurtkulağı, Gizem Kahveci and Buket Kın Tekçe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diagnostics and Postgraduate Medicine.

In The Last Decade

Buse Balci

11 papers receiving 345 citations

Hit Papers

Is serum uric acid-to-HDL cholesterol ratio elevation ass... 2023 2026 2024 2025 2023 25 50 75

Peers

Buse Balci
Buse Balci
Citations per year, relative to Buse Balci Buse Balci (= 1×) peers Mehmet Ali Kösekli

Countries citing papers authored by Buse Balci

Since Specialization
Citations

This map shows the geographic impact of Buse Balci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Buse Balci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Buse Balci more than expected).

Fields of papers citing papers by Buse Balci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Buse Balci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Buse Balci. The network helps show where Buse Balci may publish in the future.

Co-authorship network of co-authors of Buse Balci

This figure shows the co-authorship network connecting the top 25 collaborators of Buse Balci. A scholar is included among the top collaborators of Buse Balci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Buse Balci. Buse Balci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Balci, Buse, et al.. (2024). A novel marker for prediabetic conditions: Uric acid-to-HDL cholesterol ratio. Bratislavské lekárske listy/Bratislava medical journal. 125(3). 145–148. 28 indexed citations
2.
Balci, Buse, Buket Kın Tekçe, & Gülali Aktaş. (2024). Evaluation of serum oxidative stress levels and antioxidant capacity in prediabetes. SHILAP Revista de lepidopterología. 12. 100106–100106. 13 indexed citations
3.
Duman, Tuba Taslamacıoğlu, et al.. (2023). Could Systemic Inflammatory Index Predict Diabetic Kidney Injury in Type 2 Diabetes Mellitus?. Diagnostics. 13(12). 2063–2063. 34 indexed citations
4.
Balci, Buse, et al.. (2023). A Novel Inflammatory Marker for the Diagnosis of Hashimoto’s Thyroiditis: Platelet-Count-to-Lymphocyte-Count Ratio. SHILAP Revista de lepidopterología. 11(1). 15–15. 25 indexed citations
5.
Aktaş, Gülali, et al.. (2023). Treatment of type 2 diabetes patients with heart conditions. Expert Review of Endocrinology & Metabolism. 18(3). 255–265. 34 indexed citations
6.
Aktaş, Gülali, et al.. (2023). Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury?. Postgraduate Medicine. 135(5). 519–523. 93 indexed citations breakdown →
9.
Kahveci, Gizem, Gülali Aktaş, Satılmış Bilgin, et al.. (2022). Red cell distribution width-to-platelet count ratio is a promising predictor of functional bowel disease. SHILAP Revista de lepidopterología. 24(2). 126–129.
10.
Bilgin, Satılmış, Gülali Aktaş, Özge Kurtkulağı, et al.. (2021). Triglyceride to high density lipoprotein cholesterol ratio is elevated in patients with complicated type 2 diabetes mellitus. AFMN Biomedicine. 39(1). 66–73. 15 indexed citations
11.
Bilgin, Satılmış, Burçin Meryem Atak Tel, Gizem Kahveci, et al.. (2021). Hypothyroidism is Strongly Correlated with Mean Platelet Volume and Red Cell Distribution Width. Çanakkale Onsekiz Mart University AVESIS. 6(1). 7–10. 19 indexed citations
12.
Kurtkulağı, Özge, Burçin Meryem Atak Tel, Gizem Kahveci, et al.. (2021). Hashimoto’s thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio. Romanian Journal of Internal Medicine. 59(4). 403–408. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026